W. E. van Heyningen
Impact in
- Endocrinology top 1%
- Escherichia coli research studies
- Vibrio bacteria research studies
- Neurology top 5%
- Botulinum Toxin and Related Neurological Disorders
Papers in
-
- Glycosylation and Glycoproteins Research 13
- Lipid Membrane Structure and Behavior 3
- Immunology 11
- Toxin Mechanisms and Immunotoxins 11
- Co-authors
- C. A. King (5 shared papers)Pauline A. Miller (1 shared paper)W. B. Greenough (1 shared paper)N. F. Pierce (1 shared paper)Charles C. J. Carpenter (1 shared paper)John Mellanby (2 shared papers)Jane Mellanby (3 shared papers)Paul Fildes (1 shared paper)
- Journals
- The Journal of Infectious Diseases (5 papers)Nature (3 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (2 papers)Scientific American (1 paper)Novartis Foundation symposium (1 paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
W. E. van Heyningen
35 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 111
- Endocrinology 355
- Neurology 303
- Immunology 428
- Pharmacology 139
- Molecular Biology 919
Countries citing papers authored by W. E. van Heyningen
This map shows the geographic impact of W. E. van Heyningen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. E. van Heyningen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. E. van Heyningen more than expected).
Fields of papers citing papers by W. E. van Heyningen
This network shows the impact of papers produced by W. E. van Heyningen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. E. van Heyningen. The network helps show where W. E. van Heyningen may publish in the future.
Co-authors
The 25 scholars most cited alongside W. E. van Heyningen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1974 | 297 | |
| 2 | 1973 | 240 | |
| 3 | 1971 | 224 | |
| 4 | 1961 | 132 | |
| 5 | 1963 | 101 | |
| 6 | 1959 | 76 | |
| 7 | 1959 | 53 | |
| 8 | 1968 | 48 | |
| 9 | Cape Town: The making of a city : an illustrated social history | 1998 | 46 |
| 10 | 1959 | 40 | |
| 11 | 1954 | 39 | |
| 12 | 1968 | 33 | |
| 13 | The neurotoxin of Shigella shigae. III. The effect of iron on production of the toxin. | 1953 | 31 |
| 14 | 1973 | 30 | |
| 15 | 1965 | 27 | |
| 16 | 1975 | 21 | |
| 17 | 1976 | 20 | |
| 18 | 1976 | 20 | |
| 19 | 1976 | 16 | |
| 20 | 1973 | 16 |
About W. E. van Heyningen
W. E. van Heyningen is a scholar working on Molecular Biology, Immunology, Endocrinology, Neurology and Pharmacology, having authored 36 papers that have together received 1.6k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (13 papers), Toxin Mechanisms and Immunotoxins (11 papers), Botulinum Toxin and Related Neurological Disorders (7 papers), Escherichia coli research studies (6 papers), Plant-based Medicinal Research (4 papers), Diet, Metabolism, and Disease (3 papers), Lipid Membrane Structure and Behavior (3 papers) and Vibrio bacteria research studies (2 papers). The work is most often cited by research in Endocrinology (355 citations), Neurology (303 citations), Immunology (428 citations), Pharmacology (139 citations) and Molecular Biology (919 citations). W. E. van Heyningen has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include C. A. King, Pauline A. Miller, W. B. Greenough, N. F. Pierce, Charles C. J. Carpenter, John Mellanby, Jane Mellanby, Paul Fildes, G. P. Gladstone and Vivian Bickford‐Smith. Their work appears in journals such as The Journal of Infectious Diseases, Nature, Naunyn-Schmiedeberg s Archives of Pharmacology, Scientific American and Novartis Foundation symposium.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.